A Study to Determine if 0.6% ISV-403 is Safe and Effective in the Treatment of Bacterial Conjunctivitis.

Exclusion Criteria

• •Pregnant or nursing females.
• •Known hypersensitivity to fluoroquinolones or to any of the study ingredients.
• •Use of any antibiotic within 72 hours of treatment.
• •Any disease or condition that could interfere with the safety and efficacy evaluations of the study medications.
• •Participation in an ophthalmic drug or device research study within 30 days prior to entry into the study.